HeartSciences Inc.
Raising nowPublicFintech · Southlake, TX
HeartSciences develops healthcare software that applies artificial intelligence to electrocardiograms. Its first product, MyoVista Insights, is a cloud-based ECG management platform that works with any vendor's devices and hosts AI-ECG algorithms from multiple vendors. It also developed the MyoVista wavECG device, which is awaiting FDA clearance.
This company has an open fundraising round.
Financials
FY2022–FY2026 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inDotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.
Share price over rounds
Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.
Cap table
Share counts as of Jul 31, 2026| Class | Outstanding | Votes / share | Share of total | Liquidation | Last price |
|---|---|---|---|---|---|
| preferred stockpreferred | 425,264 | — | 8.28% | — | — |
| Series D Preferred Stockpreferred | 425,264 | — | 8.28% | — | $2.43Jul 2026 |
| Series C Preferred Stockpreferred | 380,440 | — | 7.41% | 1× participating | — |
| Common Stock | 3,904,983 | — | 76.0% | — | — |
| Total | 5,135,951 | 100% |
Shares outstanding over timein today's share terms
Changes in named holdersshares in today's terms · % of all shares at the time
- Andrew Simpson6K (6.82%) Jul 2022 → 6K (5.13%) Jul 2023 → 6K (0.46%) Feb 2025 → 11K (0.42%) Jul 2025 → 88K (6.05%) Apr 2026 → 93K (7.55%) Jul 2026
- Brian Szymczak4 (0%) Jul 2022 → 400 (0.03%) Jul 2024 → 2K (0.18%) Feb 2025 → 4K (0.15%) Jul 2025 → 20K (1.34%) Apr 2026 → 26K (2.09%) Jul 2026
- Bruce Bent35 (0.04%) Jul 2022 → 2K (0.15%) Feb 2025 → 4K (0.13%) Jul 2025 → 19K (1.31%) Apr 2026 → 25K (2.05%) Jul 2026
- Danielle Watson45 (0.05%) Jul 2022 → 68 (0.06%) Jul 2023 → 531 (0.04%) Feb 2025 → 657 (0.02%) Jul 2025 → 2K (0.12%) Apr 2026 → 3K (0.23%) Jul 2026
- David R. Wells2K (0.15%) Feb 2025 → 5K (0.18%) Jul 2025 → 19K (1.31%) Apr 2026 → 25K (2.05%) Jul 2026
- Front Range Ventures, LLC1K (1.73%) Jul 2022 → 148K (11.5%) Jul 2024
- Mark Hilz6K (6.75%) Jul 2022 → 6K (5.05%) Jul 2023 → 2K (0.16%) Jul 2024 → 8K (0.58%) Feb 2025 → 9K (0.33%) Jul 2025 → 2K (0.14%) Apr 2026
- John H. Matthews9K (10.7%) Jul 2022 → 8K (7.39%) Jul 2023 → 52K (4.07%) Jul 2024
Principal holders% as the filing states it, Jul 23, 2026
- Front Range Ventures, LLC148,213 Series C Preferred Stock39.0%of Series C Preferred
- Ephraim Fields265,218 Common Stock6.8%of
- Front Range Ventures, LLC116,093 Common Stock2.9%of
- Andrew Simpson92,959 Common Stock2.3%of
- Andrew Simpson6,117 Series C Preferred Stock1.6%of Series C Preferred
- Bruce Bent25,286 Common Stock—of votes
- Danielle Watson2,842 Common Stock—of votes
- David R. Wells25,250 Common Stock—of votes
- Brian Szymczak400 Series C Preferred Stock—of votes
- Brian Szymczak25,722 Common Stock—of votes
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
SEC filings
View all 41 filings on EDGAR- Form 10-QSep 14, 20260001437749-26-030319EDGAR
- Form 10-KJul 23, 20260001437749-26-024337EDGAR
- Form 253G2Jun 1, 20260001213900-26-063574EDGAR
- Form 253G2Apr 17, 20260001213900-26-045239EDGAR
- Form QUALIFApr 17, 20269999999994-26-000080EDGAR
- Form 1-A POSApr 10, 20260001213900-26-042552EDGAR
- Form 10-QMar 16, 20260001437749-26-008399EDGAR
- Form 10-QDec 15, 20250001193125-25-319203EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.